Impact of KRAS mutation on non-small cell lung cancer survival outcomes

被引:0
|
作者
Thomas, Q. [1 ]
Lemercier, P. [2 ]
Justeau, G. [3 ]
Schneider, S. [4 ]
Filleron, T. [5 ]
Masip, J. Remon [6 ]
Perol, M. [7 ]
Girard, N. [8 ]
Debieuvre, D. [9 ]
Valette, C. Audigier [10 ]
Chouaid, C. [11 ]
Loeb, A. [12 ]
Hiret, S. [13 ]
Clement-Duchene, C. [14 ]
Dansin, E. [15 ]
Stancu, A. T. [16 ]
Dubray-Longeras, P. [17 ]
Pichon, E. [18 ]
Bosquet, L. [19 ]
Quantin, X. [1 ]
机构
[1] ICM Inst Canc Montpellier, Dept Oncol, Montpellier, France
[2] ICM Inst Canc Montpellier, Biometr Unit, Montpellier, France
[3] CHU Angers, Pneumol, Angers, France
[4] Ctr Hosp Cote Basque, Pyrenees Atlant, Bayonne, France
[5] IUCT Oncopole, Haute Garonne, Inst Claudius Regaud, Toulouse, France
[6] Inst Gustave Roussy, Dept Oncol, Villejuif, France
[7] Ctr Leon Berard, Dept Med Oncol, Lyon, France
[8] Thorax Inst, Inst Curie, Paris, France
[9] GHRMSA, Pneumol, Mulhouse, France
[10] Hop Sainte Musse, Pneumol, Toulon, France
[11] CH Intercommunal Creteil, Pneumol, Creteil, France
[12] Ctr Henri Becquerel, Pneumol, Rouen, France
[13] ICO Inst Cancerol IOuest Rene Gauducheau, Dept Oncol, St Herblain, France
[14] Inst Cancerol Lorraine Alexis Vautrin, Dept Oncol, Vandoeuvre Les Nancy, France
[15] Ctr Oscar Lambret, Dept Oncol, Lille, France
[16] Inst Sainte Catherine, Pneumol, Avignon, France
[17] Ctr Jean Perrin, Pneumol, Clermont Ferrand, France
[18] CHRU Hop Tours, Pneumol, Hop Bretonneau, Tours, France
[19] UNICANCER, Real World Data, Paris, France
关键词
D O I
10.1016/j.annonc.2023.09.2433
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1401P
引用
下载
收藏
页数:1
相关论文
共 50 条
  • [21] Editorial: Factors that impact the survival of non-small cell lung cancer
    Hegi-Johnson, Fiona
    Higgins, Kristin A.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [22] The Impact of Sex on Non-Small Cell Lung Cancer Survival in Canada
    Ford-Sahibzada, C.
    Dean, M.
    Peters, C.
    Brenner, D.
    Gibson, A.
    Tudor, R.
    Elegbede, A.
    D'Silva, A.
    Cheung, W.
    Bebb, G.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S946 - S947
  • [23] EVALUATION OF KRAS GENE MUTATION AND COPY NUMBER GAIN IN NON-SMALL CELL LUNG CANCER
    Sasaki, Hidefumi
    Okuda, Katsuhiro
    Hikosaka, Yu
    Moriyama, Satoru
    Yano, Motoki
    Fujii, Yoshitaka
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S945 - S945
  • [24] Sotorasib: First Approved KRAS Mutation Inhibitor for the Treatment of Non-small Cell Lung Cancer
    De, Surya K. K.
    CURRENT MEDICINAL CHEMISTRY, 2023, 30 (09) : 1000 - 1002
  • [25] KRAS mutation is highly correlated with EGFR alterations in patients with non-small cell lung cancer
    Wang, J. -Y.
    Lin, S. -R.
    EJC SUPPLEMENTS, 2009, 7 (04): : 37 - 37
  • [26] Prevention of non-small cell lung cancer with kras mutation using a novel peptide vaccine
    Wang, Suhe
    Cao, Zhengyi
    Chen, Jesse
    Katarzyna, Janczak
    Baker, James
    CANCER RESEARCH, 2022, 82 (12)
  • [27] Evaluation of Kras Gene Mutation and Copy Number Gain in Non-small Cell Lung Cancer
    Sasaki, Hidefumi
    Hikosaka, Yu
    Kawano, Osamu
    Moriyama, Satoru
    Yano, Motoki
    Fujii, Yoshitaka
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (01) : 15 - 20
  • [28] A novel intranasal peptide vaccine inhibits non-small cell lung cancer with KRAS mutation
    Su He Wang
    Zhengyi Cao
    Mohammad Farazuddin
    Jesse Chen
    Katarzyna W. Janczak
    Shengzhuang Tang
    Jayme Cannon
    James R. Baker
    Cancer Gene Therapy, 2024, 31 : 464 - 471
  • [29] Identification of a KRAS mutation in a patient with non-small cell lung cancer treated with chemoradiotherapy and panitumumab
    Zaorsky, Nicholas G.
    Sun, Yunguang
    Wang, Zixuan
    Palmer, Joshua
    Fortina, Paolo M.
    Solomides, Charalambos
    Werner-Wasik, Maria
    Dicker, Adam P.
    Axelrod, Rita
    Campling, Barbara
    Evans, Nathaniel, III
    Cowan, Scott
    Lu, Bo
    CANCER BIOLOGY & THERAPY, 2013, 14 (10) : 883 - 887
  • [30] A novel intranasal peptide vaccine inhibits non-small cell lung cancer with KRAS mutation
    Wang, Su He
    Cao, Zhengyi
    Farazuddin, Mohammad
    Chen, Jesse
    Janczak, Katarzyna W.
    Tang, Shengzhuang
    Cannon, Jayme
    Baker Jr, James R.
    CANCER GENE THERAPY, 2024, 31 (03) : 464 - 471